{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:31:12Z","timestamp":1793745072680,"version":"4.6.1"},"reference-count":37,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Joint Research Council at St. Olavs Hospital HF\u2014Trondheim University Hospital"},{"name":"Faculty of Medicine, Norwegian University of Science and Technology"},{"name":"Liaison Committee for Education, Research and Innovation in Central Norway","award":["2020\/28254"],"award-info":[{"award-number":["2020\/28254"]}]},{"name":"Liaison Committee for Education, Research and Innovation in Central Norway","award":["2020\/39645"],"award-info":[{"award-number":["2020\/39645"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Cancer cachexia is a complex syndrome marked by involuntary weight and muscle loss, often driven by systemic inflammation. This multicenter, longitudinal observational study investigated circulating microRNA (miRNA) profiles in patients with unresectable locally advanced or metastatic colorectal cancer, comparing those with and without cachexia and inflammation. A total of 168 patients were categorized into four groups based on cachexia and C-reactive protein (CRP) levels. Cachexia was defined using the 2011 consensus criteria, incorporating weight loss, low BMI, and sarcopenia. Patients with both cachexia and systemic inflammation exhibited significantly distinct miRNA profiles as well as poorer overall survival (HR 2.10, p &lt; 0.001) compared to patients with neither condition. No significant differences were observed in patients lacking either cachexia or inflammation or both. Inflammatory cachexia emerged as a biologically distinct entity, with 82 differentially expressed miRNAs. The miR-320-family, miR-6087, miR-4488, miR-29a-3p, miR-194-5p, and miR-10a-5p were most altered, several of which are linked to muscle mass, metabolism, lipid, and protein synthesis. These findings highlight the pivotal role of systemic inflammation in cancer cachexia and support its inclusion in diagnostic criteria. Moreover, circulating miRNAs may serve as promising biomarkers for identifying cachexia in cancer patients.<\/jats:p>","DOI":"10.3390\/curroncol32110620","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:02:03Z","timestamp":1762419723000},"page":"620","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum miRNA Signatures in Cancer Cachexia Depend on Systemic Inflammation"],"prefix":"10.3390","volume":"32","author":[{"given":"Terese Louise Schmidberger","family":"Karlsen","sequence":"first","affiliation":[{"name":"Cancer Clinic, St. Olavs Hospital, 7030 Trondheim, Norway"},{"name":"Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Mjelle","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9419-5969","authenticated-orcid":false,"given":"Ola Magne","family":"Vagnildhaug","sequence":"additional","affiliation":[{"name":"Cancer Clinic, St. Olavs Hospital, 7030 Trondheim, Norway"},{"name":"Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5715-4268","authenticated-orcid":false,"given":"Trude Rakel","family":"Balstad","sequence":"additional","affiliation":[{"name":"Cancer Clinic, St. Olavs Hospital, 7030 Trondheim, Norway"},{"name":"Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway"},{"name":"Department of Clinical Medicine, Clinical Nutrition Research Group, UiT The Arctic University of Norway, 9019 Troms\u00f8, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Are Korsnes","family":"Kristensen","sequence":"additional","affiliation":[{"name":"Cancer Clinic, St. Olavs Hospital, 7030 Trondheim, Norway"},{"name":"Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Erik","family":"Slagsvold","sequence":"additional","affiliation":[{"name":"Cancer Clinic, St. Olavs Hospital, 7030 Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganna S.","family":"Westwik","sequence":"additional","affiliation":[{"name":"Cancer Clinic, Levanger Hospital, Nord-Tr\u00f8ndelag Health Trust, 7601 Levanger, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege","family":"Elvebakken","sequence":"additional","affiliation":[{"name":"Department of Oncology, M\u00f8re & Romsdal Hospital Trust, 6017 \u00c5lesund, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hofsli","sequence":"additional","affiliation":[{"name":"Cancer Clinic, St. Olavs Hospital, 7030 Trondheim, Norway"},{"name":"Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingunn","family":"Hatlevoll","sequence":"additional","affiliation":[{"name":"Cancer Clinic, St. Olavs Hospital, 7030 Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2565-8437","authenticated-orcid":false,"given":"Tora Skeidsvoll","family":"Solheim","sequence":"additional","affiliation":[{"name":"Cancer Clinic, St. Olavs Hospital, 7030 Trondheim, Norway"},{"name":"Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Mitchell, T., Clarke, L., Goldberg, A., and Bishop, K.S. (2019). Pancreatic Cancer Cachexia: The Role of Nutritional Interventions. Healthcare, 7.","DOI":"10.3390\/healthcare7030089"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","article-title":"GLIM criteria for the diagnosis of malnutrition\u2014A consensus report from the global clinical nutrition community","volume":"38","author":"Cederholm","year":"2019","journal-title":"Clin. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","article-title":"Origins and Mechanisms of miRNAs and siRNAs","volume":"136","author":"Carthew","year":"2009","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"367561","DOI":"10.1155\/2015\/367561","article-title":"Cancer Cachexia and MicroRNAs","volume":"2015","author":"Camargo","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Das, K., and Rao, L.V.M. (2022). The Role of microRNAs in Inflammation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415479"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug. Discov."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, J., Hayder, H., Zayed, Y., and Peng, C. (2018). Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00402"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1073\/pnas.1402714111","article-title":"Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7","volume":"111","author":"He","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"21274","DOI":"10.1002\/jcp.28732","article-title":"Chronic myeloid leukemia-derived exosomes attenuate adipogenesis of adipose derived mesenchymal stem cells via transporting miR-92a-3p","volume":"234","author":"Wan","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/jcsm.12168","article-title":"Small RNAome profiling from human skeletal muscle: Novel miRNAs and their targets associated with cancer cachexia","volume":"8","author":"Narasimhan","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/jcsm.12512","article-title":"Identification of microRNAs in skeletal muscle associated with lung cancer cachexia","volume":"11","author":"Schols","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"E267","DOI":"10.1152\/ajpendo.00249.2013","article-title":"MicroRNA profiling links miR-378 to enhanced adipocyte lipolysis in human cancer cachexia","volume":"306","author":"Gao","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jcsm.13224","article-title":"Specific miRNAs are associated with human cancer cachexia in an organ-specific manner","volume":"14","author":"Krauss","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Santos, J.M.O., da Silva, S.P., da Costa, R.M.G., and Medeiros, R. (2020). The Emerging Role of MicroRNAs and Other Non-Coding RNAs in Cancer Cachexia. Cancers, 12.","DOI":"10.3390\/cancers12041004"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Powr\u00f3zek, T., Mlak, R., Brzozowska, A., Mazurek, M., Go\u0142\u0119biowski, P., and Ma\u0142ecka-Massalska, T. (2018). miRNA-130a Significantly Improves Accuracy of SGA Nutritional Assessment Tool in Prediction of Malnutrition and Cachexia in Radiotherapy-Treated Head and Neck Cancer Patients. Cancers, 10.","DOI":"10.3390\/cancers10090294"},{"key":"ref_21","first-page":"1555","article-title":"Prognostic impact of sarcopenia and its correlation with circulating miR-21 in colorectal cancer patients","volume":"39","author":"Okugawa","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/jcsm.12403","article-title":"Circulating miR-203 derived from metastatic tissues promotes myopenia in colorectal cancer patients","volume":"10","author":"Okugawa","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Yehia, R., Schaalan, M., Abdallah, D.M., Saad, A.S., Sarhan, N., and Saleh, S. (2021). Impact of TNF-\u03b1 Gene Polymorphisms on Pancreatic and Non-Small Cell Lung Cancer-Induced Cachexia in Adult Egyptian Patients: A Focus on Pathogenic Trajectories. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.783231"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12944-021-01530-9","article-title":"miR-410-3P inhibits adipocyte differentiation by targeting IRS-1 in cancer-associated cachexia patients","volume":"20","author":"Sun","year":"2021","journal-title":"Lipids Health Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1002\/jcsm.13343","article-title":"Small non-coding RNA profiling in patients with gastrointestinal cancer","volume":"14","author":"Molfino","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Tambaro, F., Imbimbo, G., Pace, V., Amabile, M.I., Rizzo, V., Orlando, S., Lauteri, G., Ramaccini, C., Catalano, C., and Nigri, G. (2024). Circulating adipose-tissue miRNAs in gastrointestinal cancer patients and their association with the level and type of adiposity at body composition analysis. Front. Mol. Biosci., 11.","DOI":"10.3389\/fmolb.2024.1449197"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"217523","DOI":"10.1016\/j.canlet.2025.217523","article-title":"Tumor-derived miR-203a-3p potentiates muscle wasting by inducing muscle ferroptosis in pancreatic cancer","volume":"614","author":"Hu","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_28","unstructured":"(2015). A Longitudinal Study of Colorectal Cancer Patients with Metastatic Disease in Middle-Norway, ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02395224?term=A+longitudinal+study+of+colorectal+cancer+patients+with+metastatic+disease+in+Middle-Norway&draw=2&rank=1."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.clnu.2023.04.021","article-title":"Comparison of the performance of the GLIM criteria, PG-SGA and mPG-SGA in diagnosing malnutrition and predicting survival among lung cancer patients: A multicenter study","volume":"42","author":"Huo","year":"2023","journal-title":"Clin. Nutr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12943-024-02042-7","article-title":"Serum small RNAs in metastatic colorectal cancer predict response to chemotherapy and characterize high-risk patients","volume":"23","author":"Mjelle","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"90077","DOI":"10.18632\/oncotarget.21412","article-title":"Identification of metastasis-associated microRNAs in serum from rectal cancer patients","volume":"8","author":"Mjelle","year":"2017","journal-title":"Oncotarget"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"W207","DOI":"10.1093\/nar\/gkad347","article-title":"g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update)","volume":"51","author":"Kolberg","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"136687","DOI":"10.1172\/jci.insight.136687","article-title":"Formation of colorectal liver metastases induces musculoskeletal and metabolic abnormalities consistent with exacerbated cachexia","volume":"5","author":"Huot","year":"2020","journal-title":"JCI Insight"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"C1283","DOI":"10.1152\/ajpcell.00448.2025","article-title":"Profibrotic immune cells and fibro-adipogenic progenitors contribute to skeletal muscle extracellular matrix remodeling and fibrosis in cancer cachexia","volume":"329","author":"Cardaci","year":"2025","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.cmet.2025.01.018","article-title":"MIF-ACKR3 causes irreversible fat loss by impairing adipogenesis in cancer cachexia","volume":"37","author":"Cui","year":"2025","journal-title":"Cell Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13395-025-00397-z","article-title":"Signaling networks governing skeletal muscle growth, atrophy, and cachexia","volume":"15","author":"Joshi","year":"2025","journal-title":"Skelet. Muscle"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/11\/620\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:12:28Z","timestamp":1762423948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/11\/620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["curroncol32110620"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32110620","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]}}}